EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype

Ana Margarida Medeiros, Ana Catarina Alves, Beatriz Miranda, Joana Rita Chora, Mafalda Bourbon, investigators of the Portuguese FH Study

Journal of Lipid Research · 2024

DOI: 10.1016/j.jlr.2023.100490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Ana Margarida Medeiros und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de I&D, Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis, Instituto Nacional…. Hauptthemen laut MEDLINE: Hypercholesterolemia, Hyperlipoproteinemia Type II. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology, Portuguese Cardiology Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hypercholesterolemia (FH) is a common genetic disorder of lipid metabolism caused by pathogenic/likely pathogenic variants in LDLR, APOB, and PCSK9 genes. Variants in FH-phenocopy genes (LDLRAP1, APOE, LIPA, ABCG5, and ABCG8), polygenic hypercholesterolemia, and hyperlipoprotein (a) [Lp(a)] can also mimic a clinical FH phenotype. We aim to present a new diagnostic tool to unravel the genetic background of clinical FH phenotype. Biochemical and genetic study was performed in 1,005 individuals with clinical diagnosis of FH, referred to the Portuguese FH Study. A next-generation sequencing panel, covering eight genes and eight SNPs to determine LDL-C polygenic risk score and LPA genetic score, was validated, and used in this study. FH was genetically confirmed in 417 index cases: 408 heterozygotes and 9 homozygotes. Cascade screening increased the identification to 1,000 FH individuals, including 11 homozygotes. FH-negative individuals (phenotype positive and genotype negative) have Lp(a) >50 mg/dl (30%), high polygenic risk score (16%), other monogenic lipid metabolism disorders (1%), and heterozygous pathogenic variants in FH-phenocopy genes (2%). Heterozygous variants of uncertain significance were identified in primary genes (12%) and phenocopy genes (7%). Overall, 42% of our cohort was genetically confirmed with FH. In the remaining individuals, other causes for high LDL-C were identified in 68%. Hyper-Lp(a) or polygenic hypercholesterolemia may be the cause of the clinical FH phenotype in almost half of FH-negative individuals. A small part has pathogenic variants in ABCG5/ABCG8 in heterozygosity that can cause hypercholesterolemia and should be further investigated. This extended next-generation sequencing panel identifies individuals with FH and FH-phenocopies, allowing to personalize each person's treatment according to the affected pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaHyperlipoproteinemia Type IIHumansProprotein Convertase 9Cholesterol, LDLPhenotypeGenetic BackgroundReceptors, LDLMutation

Stichwörter der Autor:innen

FH-phenocopy genesfamilial hypercholesterolemiahyper-Lp(a)polygenic hypercholesterolemia

Substanzen

PCSK9 protein, humanProprotein Convertase 9Cholesterol, LDLReceptors, LDL

Autor:innen und Institutionen

  • Unidade de I&D, Grupo de Investigação Cardiovascular, Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisboa, Portugal; BioISI - Biosystems…

Förderung

  • Foundation for Science and Technology
  • Portuguese Cardiology Society

Zitieren

APA

Medeiros, A. M., Alves, A. C., Miranda, B., Chora, J. R., Bourbon, M., & investigators of the Portuguese FH Study (2024). Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2023.100490

Vancouver

Medeiros AM, Alves AC, Miranda B, Chora JR, Bourbon M, investigators of the Portuguese FH Study. Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2023.100490

BibTeX
@article{Medeiros2024,
  author = {Medeiros, Ana Margarida and Alves, Ana Catarina and Miranda, Beatriz and Chora, Joana Rita and Bourbon, Mafalda and investigators of the Portuguese FH Study, investigators of the Portuguese FH Study},
  title = {Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype},
  journal = {Journal of Lipid Research},
  year = {2024},
  doi = {10.1016/j.jlr.2023.100490}
}
Kostenlos starten →